MorphogeniQ
ActiveSummary
MorphogeniQ has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,056 and a net result of €3,056. Its solvency ranks better than 28% of 13,595 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Directors
Directors
1 director, no change since 2025
Luc Meeuwissen
CurrentGewoon bestuurder · since 25-07-2024
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
2 people since 2024, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Luc Meeuwissen |
|
| Michel Aerts |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
Stated in the act
act of 28-11-2025 ↗
- Meeuwissen,Luc François Isabelle all shares
Share transfer
act of 28-11-2025 ↗
- parties not read
At incorporation
act of 25-07-2024 ↗
- MEEUWISSEN Luc François Isabelle founder
- AERTS Michel founder
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 25-07-2024 Incorporation · 10,000 shares